Endothelin activates MAP kinases exclusively through the ETA receptor in glomerular mesangial cells, providing insight into postreceptor signaling pathways in renal pathophysiology.
No takes yet. Share an insight, caveat, or question.
ETA exclusivity in mesangial signaling does not alter renal therapies; leaves open in vivo and human translation.
Wang et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: